Rentokil Initial stock gains as SOLitude sale raises USD 230 million

Published on 09/22/2026 at 13:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Rentokil Initial stock traded at USD 21.34 on September 21, 2026, down 27.6 percent year to date. The SOLitude sale adds USD 180 million after tax.

RTO, US76169Y1001, Illustration mit AI erstellt.

Rentokil Initial plc (US76169Y1001) closed at USD 21.34 on the NYSE on September 21, 2026, down USD 0.01, or 0.05 percent, from the prior close. The company then announced the sale of SOLitude Lake Management and Vertex Aquatic Solutions to Bain Capital for USD 230 million.

Sale adds USD 180 million

According to Rentokil Initial on September 22, 2026, estimated net cash proceeds after tax are USD 180 million. The transaction is subject to Hart-Scott-Rodino clearance and is expected to complete in the fourth quarter of 2026.

The disposal gives the pest control and hygiene group a defined cash inflow while removing a non-core US lake and pond management business. According to Borsa Italiana on September 22, 2026, SOLitude generated USD 112 million of revenue and USD 16 million of adjusted operating profit in fiscal year 2025.

Stock remains below yearly high

MarketBeat data show a 52-week range of USD 21.07 to USD 34.67, with market capitalization of USD 10.78 billion and volume of 1.72 million shares at the September 21, 2026 close. The closing price was therefore USD 0.27 above the 52-week low and USD 13.33 below the 52-week high.

The comparison with the start of 2026 is material: Rentokil Initial shares were quoted at USD 29.48 at the beginning of the year, versus USD 21.34 on September 21, a decline of 27.6 percent. The transaction provides a measurable balance-sheet and capital-allocation event against that weaker share-price backdrop.

Cash supports capital allocation

Rentokil Initial said on September 22, 2026, that the transaction further reduces leverage within its target range. The company linked the proceeds to organic growth, bolt-on acquisitions, a progressive dividend and potential returns of surplus capital.

Revenue visibility also provides an operating reference point. As Halifax reported on September 22, 2026, Rentokil had a backlog of GBP 193 million at June 30, 2026, while GBP 168 million of forecast fiscal year 2026 revenue was covered by contracted orders as of September.

Rentokil Initial stock at USD 21.34

Rentokil Initial stock closed at USD 21.34 on the NYSE on September 21, 2026, with the daily change at minus 0.05 percent. The USD 230 million sale, USD 180 million estimated after-tax proceeds and USD 112 million of fiscal year 2025 SOLitude revenue define the latest market and operating reference points.